Table 3.
hsa-miRNA | Patients with HT (n = 24) | Healthy Subjects (n = 17) | p-Value |
---|---|---|---|
miR-21-5p | −0.43 ± 0.54 | 0.68 ± 0.58 | <0.001 * |
miR-22-3p | 1.58 ± 0.85 | 2.98 ± 0.80 | <0.001 * |
miR-22-5p | 6.42 ± 0.95 | 7.22 ± 0.91 | 0.010 |
miR-96-5p | 8.40 ± 1.21 | 9.22 ± 1.22 | 0.040 |
miR-142-3p | −0.84 ± 0.58 | 1.03 ± 0.60 | <0.001 * |
miR-146a-5p | 2.71 ± 0.63 | 3.69 ± 0.65 | <0.001 * |
miR-301-3p | 6.09 ± 1.01 | 7.21 ± 0.82 | 0.001 * |
miR-375 | 8.52 ± 1.67 | 8.21 ± 1.10 | 0.503 |
miR-451 | −2.60 ± 1.00 | 2.82 ± 1.35 | <0.001 * |
* indicates significant p-values after Bonferroni correction.